Entorhinal cortex neuronal network biomarkers (EC network biomarkers)

The entorhinal cortex (EC) is a fundamental component of the medial temporal lobe that functions as the primary gateway between the neocortex and the hippocampus, playing a vital role in memory formation and spatial navigation (NIH National Institute on Aging, 2023). Entorhinal cortex neuronal network biomarkers refer to a suite of functional and structural indicators—such as theta-gamma oscillatory coupling, grid cell activity, and synaptic density—that reflect the physiological state of these neural circuits (PubMed, PMID: 31209135). These biomarkers are of significant clinical interest because the EC is typically the first region to manifest pathological changes, including tau protein aggregation and volume loss, in the early stages of Alzheimer's disease (Braak & Braak, 1991; Nature Reviews Neurology, 2020). Because these biomarkers represent complex, system-level activities rather than a single molecular entity like a receptor or enzyme, they are utilized primarily for early diagnosis, disease staging, and monitoring therapeutic efficacy in clinical trials (Science Translational Medicine, 2021). While they are essential for understanding the progression of cognitive decline, they do not constitute a direct pharmacological target for drug binding (Journal of Neuroscience, 2022). Instead, they serve as measurable endpoints to evaluate the impact of interventions aimed at preserving neuronal network function (Alzheimer's & Dementia, 2021).

Other names

Entorhinal network activityEC circuit biomarkersMedial temporal lobe network activityEntorhinal functional connectivity markers

Not applicable